Association of brain-derived neurotrophic factor gene Val66Met polymorphism with primary dysmenorrhea

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Lee, Lin Chien ^a,b,c   Tu, Cheng Hao ^a,c,d   Chen, Li Fen ^a,c   Shen, Horng Der ^c   Chao, Hsiang Tai ^a,c   Lin, Ming Wei ^a,c   Hsieh, Jen Chuen ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DEMOGRAPHY; DYSMENORRHEA; EMOTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MENSTRUAL CYCLE; MOOD DISORDER; NEUROIMAGING; PREVALENCE; QUALITY OF LIFE; SCORING SYSTEM; TAIWANESE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; YOUNG ADULT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DYSMENORRHEA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHIONINE; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; VALINE; YOUNG ADULT;

EID: 84911410793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112766     Document Type: Article

References (71)

1. French L (2005) Dysmenorrhea. Am Fam Physician 71: 285-291.
2. Davis AR, Westhoff CL (2001) Primary dysmenorrhea in adolescent girls andtreatment with oral contraceptives. J Pediatr Adolesc Gynecol 14: 3-8.
3. Fedorowicz Z, Nasser M, Jagannath VA, Beaman JH, Ejaz K, et al. (2012)Beta2-adrenoceptor agonists for dysmenorrhoea. Cochrane Database Syst Rev 5: Cd008585.
4. Berkley K J (2013) Primary dysmenorrhea: an urgent mandate. Pain: Clinical Updates XXI NO3: 1-8.
5. Guo SW, Mao X, Ma Q, Liu X (2013) Dysmenorrhea and its severity areassociated with increased uterine contractility and overexpression of oxytocinreceptor (OTR) in women with symptomatic adenomyosis. Fertil Steril 99: 231-240.
6. Akerlund M (1994) Vascularization of human endometrium. Uterine blood flowin healthy condition and in primary dysmenorrhoea. Ann N Y Acad Sci 734:47-56.
7. Ma H, Hong M, Duan J, Liu P, Fan X, et al. (2013) Altered cytokine geneexpression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: A case-control study. PLoS One 8: e55200.
8. Abu JI, Konje JC (2000) Leukotrienes in gynaecology: the hypothetical value ofanti-leukotriene therapy in dysmenorrhoea and endometriosis. Hum Reprod Update 6: 200-205.
9. Akerlund M (2006) Targeting the oxytocin receptor to relax the myometrium.Expert Opin Ther Targets 10: 423-427.
10. Tzafettas J (2006) Painful menstruation. Pediatr Endocrinol Rev 3 Suppl 1: 160-163.
11. Sundell G, Milsom I, Andersch B (1990) Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 97: 588-594.
12. Barnard K, Frayne SM, Skinner KM, Sullivan LM (2003) Health status among women with menstrual symptoms. J Womens Health (Larchmt) 12: 911-919.
13. Alonso C, Coe CL (2001) Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women.Health Psychol 20: 411-416.
14. Dorn LD, Negriff S, Huang B, Pabst S, Hillman J, et al. (2009) Menstrual symptoms in adolescent girls: association with smoking, depressive symptoms,and anxiety. J Adolesc Health 44: 237-243.
15. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, etal. (2010) Meta-analysis of the BDNF Val66Met polymorphism in majordepressive disorder: effects of gender and ethnicity. Mol Psychiatry 15: 260-271.
16. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, et al.(2005) The impact of age, weight and gender on BDNF levels in human plateletsand plasma. Neurobiol Aging 26: 115-123.
17. Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, et al. (2008) BDNF as a pain modulator. Prog Neurobiol 85: 297-317.
18. Latremoliere A, Woolf C J (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10: 895-926.
19. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
20. Duric V, McCarson KE (2006) Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J Pain 7: 544-555.
21. Spencer JL, Waters EM, Milner TA, Lee FS, McEwen BS (2010) BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function.Proc Natl Acad Sci USA 107: 4395-4400.
22. Bath KG, Chuang J, Spencer-Segal JL, Amso D, Altemus M, et al. (2012)Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-likebehavior in female mice. Biol Psychiatry 72: 499-504.
23. Solum DT, Handa RJ (2002) Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus.J Neurosci 22: 2650-2659.
24. Blurton-Jones M, Kuan PN, Tuszynski MH (2004) Anatomical evidence for transsynaptic influences of estrogen on brain-derived neurotrophic factorexpression. J Comp Neurol 468: 347-360.
25. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, et al. (2006) Genetic variant DNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140-143.
26. Vossen H, Kenis G, Rutten B, van Os J, Hermens H, et al. (2010) The genetic nfluence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS One 5: e13641.
27. Yu H, Wang DD, Wang Y, Liu T, Lee FS, et al. (2012) Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci 32: 4092-4101.
28. Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia S (2008) Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 58:163-170.
29. Montag C, Basten U, Stelzel C, Fiebach CJ, Reuter M (2010) The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies froma genetic association study in humans. Psychiatry Res 179: 86-90.
30. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, et al. (2006) The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 27: 1834-1837.
31. Holden RR, Fekken GC, Reddon JR, Helmes E, Jackson DN (1988) Clinical reliabilities and validities of the Basic Personality Inventory. J Consult Clin Psychol 56: 766-768.
32. Ware J, Snow K, Kosinski M, Gandek B (1993) SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center.
33. Hwang RJ, Chen LF, Yeh TC, Tu PC, Tu CH, et al. (2008) The resting frontal lpha asymmetry across the menstrual cycle: a magnetoencephalographic study.Horm Behav 54: 28-33.
34. Hwang RJ, Wu CH, Chen LF, Yeh TC, Hsieh JC (2009) Female menstrual phases modulate human prefrontal asymmetry: a magnetoencephalographic study. Horm Behav 55: 203-209.
35. Tu CH, Niddam DM, Yeh TC, Lirng JF, Cheng CM, et al. (2013) Menstrual pain is associated with rapid structural alterations in the brain. Pain 154: 1718-1724.
36. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G (1983) Manual for the State-Trait Anxiety Inventory (form Y). Palo Alto, CA: Consulting Psychologists Press.
37. Beck A, Steer R (1993) Manual for the Beck Anxiety Inventory. San Antonio,TX: Psychological Corporation.
38. Beck A, Steer R, Brown G (1996) Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
39. Sullivan MJ, Bishop S, Pivik J (1995) The pain catastrophizing scale:development and validation. Psychological Assessment 7: 524-532.
40. Giamberardino MA, Berkley KJ, Iezzi S, de Bigontina P, Vecchiet L (1997) Pain threshold variations in somatic wall tissues as a function of menstrual cycle,segmental site and tissue depth in non-dysmenorrheic women, dysmenorrheic women and men. Pain 71: 187-197.
41. Granot M, Yarnitsky D, Itskovitz-Eldor J, Granovsky Y, Peer E, et al. (2001) Pain perception in women with dysmenorrhea. Obstet Gynecol 98: 407-411.
42. Bajaj P, Bajaj P, Madsen H, Arendt-Nielsen L (2002) A comparison of modality-specificsomatosensory changes during menstruation in dysmenorrheic and nondysmenorrheic women. Clin J Pain 18: 180-190.
43. Amodei N, Nelson-Gray RO (1989) Reactions of dysmenorrheic and nondysmenorrheic women to experimentally induced pain throughout the menstrual cycle. J Behav Med 12: 373-385.
44. Brinkert W, Dimcevski G, Arendt-Nielsen L, Drewes AM, Wilder-Smith OH(2007) Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and rectum. Pain 132 Suppl 1: S46-51.
45. Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, et al. (2006)Quantitative sensory testing: a comprehensive protocol for clinical trials.Eur J Pain 10: 77-88.
46. Petryshen TL, Sabeti PC, Aldinger KA, Fry B, Fan JB, et al. (2010) Populationgenetic study of the brain-derived neurotrophic factor (BDNF) gene. MolPsychiatry 15: 810-815.
47. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, et al. (2003) Association study ofa brain-derived neurotrophic-factor genetic polymorphism and mood disorders,age of onset and suicidal behavior. Neuropsychobiology 48: 186-189.
48. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS (2006) Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 1118: 176-182.
49. Obata K, Noguchi K (2006) BDNF in sensory neurons and chronic pain.Neurosci Res 55: 1-10.
50. Ren K, Dubner R (2007) Pain Facilitation and Activity-Dependent Plasticity in Pain Modulatory Circuitry: Role of BDNF-TrkB Signaling and NMDA Receptors. Mol Neurobiol 35: 224-235.
51. Di Lorenzo C, Di Lorenzo G, Daverio A, Pasqualetti P, Coppola G, et al. (2012)The Val66Met Polymorphism of the BDNF Gene Influences Trigeminal Pain-Related Evoked Responses. J Pain 13: 866-873.
52. Berkley K J, McAllister SL (2011) Don't dismiss dysmenorrhea! Pain 152: 1940-1941.
53. Westling AM, Tu FF, Griffith JW, Hellman KM (2013) The association of dysmenorrhea with noncyclic pelvic pain accounting for psychological factors.Am J Obstet Gynecol 209: 422.e1-422.e10.
54. Giamberardino MA, Costantini R, Affaitati G, Fabrizio A, Lapenna D, et al.(2010) Viscero-visceral hyperalgesia: characterization in different clinical models.Pain 151: 307-322.
55. Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, et al. (2012) Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome.Gut 61: 685-694.
56. Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, et al. (2007) Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 8: 737-745.
57. Haas L, Portela LV, Bohmer AE, Oses JP, Lara DR (2010) Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia.Neurochem Res 35: 830-834.
58. Nugraha B, Karst M, Engeli S, Gutenbrunner C (2012) Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review. Rheumatol Int 32: 2593-2599.
59. Tu C-H, Niddam DM, Chao H-T, Liu R-S, Hwang R-J, et al. (2009) Abnormalcerebral metabolism during menstrual pain in primary dysmenorrhea. Neuroimage47: 28-35.
60. Vincent K, Warnaby C, Stagg CJ, Moore J, Kennedy S, et al. (2011)Dysmenorrhoea is associated with central changes in otherwise healthy women.Pain 152: 1966-1975.
61. Quartana PJ, Campbell CM, Edwards RR (2009) Pain catastrophizing: a critical review. Expert Rev Neurother 9: 745-758.
62. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12: 1079-1088.
63. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, et al. (2009)Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 14: 681-695.
64. Hapidou EG, De Catanzaro D (1988) Sensitivity to cold pressor pain in dysmenorrheic and non-dysmenorrheic women as a function of menstrual cycle phase. Pain 34: 277-283.
65. Sherman JJ, LeResche L (2006) Does experimental pain response vary across the menstrual cycle? A methodological review. Am J Physiol Regul Integr Comp Physiol 291: R245-256.
66. Hariri AR, Drabant EM, Weinberger DR (2006) Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 59: 888-897.
67. Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33: 73-83.
68. Ignacio ZM, Reus GZ, Abelaira HM, Quevedo J (2014) Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: Insights in depression. Neuroscience 275c: 455-468.
69. Hunnerkopf R, Strobel A, Gutknecht L, Brocke B, Lesch KP (2007) Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 32: 2552-2560.
70. Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, et al. (2006)Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 141B: 387-393.
71. Sun RF, Zhu YS, Kuang WJ, Liu Y, Li SB (2011) The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia. Neurosci Lett 489: 34-37..